Carbinoxamine Maleate Extended-release Oral Suspension Suspension, Extended Release
Product Images NDC 62542-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbinoxamine Maleate Extended-release Oral Suspension (NDC 62542-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbinoxamine Maleate Label (19654 Carbinoxamine Maleate Er Label 16 Oz. Tris Neos Lb8787 Rev. 00)

Carbinoxamine Maleate Label (19654 Carbinoxamine Maleate Er Label 16 Oz. Tris Neos Lb8787 Rev. 00)
This is a prescription medicine with the NDC 62542-101-05, containing Garbinoxamine Maleate in extended-release oral suspension. It is recommended to shake well before use and dose every 12 hours. The medication is strawberry banana flavored and should be dispensed using an accurate milliliter measuring device. The usual dosage can be found in the prescribing information. It is important to store this medication at 25°C (77°F) with excursions permitted from 15° to 30°C (59° to 86°F). Always keep this and all medications out of the reach of children. Dispense in a tight, light-resistant container with child-resistant closure. This product is manufactured by Tris Pharma, Inc. for Neos Therapeutics, Denver, CO. It comes in a 16 fl oz. (480 mL) container and should be used with caution until May 2024.*
FDA Label Image
FDA Label Image

Structure 1 (Structure 1)

FDA Label Image

Structure 2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.